Literature DB >> 23315074

IL-2R signaling is essential for functional maturation of regulatory T cells during thymic development.

Guoyan Cheng1, Aixin Yu, Michael J Dee, Thomas R Malek.   

Abstract

CD4(+) Foxp3(+) regulatory T cells (Tregs) are an independent cell lineage, and their developmental progression during thymic development depends on IL-2R signaling. However, the role of IL-2R signaling during thymic Treg development remains only partially understood. The current study assessed the contribution of IL-2 to the expansion and functional programming of developing Tregs. In the absence of IL-2Rβ signaling, predominantly CD4(+) CD25(-) Foxp3(lo) T cells were found, and these cells exhibited somewhat lower expression of the proliferative marker Ki67. These immature Tregs, which represent products of failed development, were also found in normal mice and were characterized by markedly lower expression of several Treg functional molecules. Therefore, IL-2R is required for the progression, functional programming, and expansion of Tregs during thymic development. An IL-2R-signaling mutant that lowers STAT5 activation readily supported Treg functional programming, but Treg proliferation remained somewhat impaired. The requirement for IL-2 during thymic Treg expansion was best illustrated in mixed chimeras where the Tregs with mutant IL-2Rs were forced to compete with wild-type Tregs during their development. Tregs with impaired IL-2R signaling were more prevalent in the thymus than spleen in these competitive experiments. The general effectiveness of mutant IL-2Rs to support thymic Treg development is partially accounted for by a heightened capacity of thymic Tregs to respond to IL-2. Overall, our data support a model in which limiting IL-2R signaling is amplified by thymic Tregs to readily support their development and functional programming, whereas these same conditions are not sufficient to support peripheral Treg homeostasis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23315074      PMCID: PMC3563871          DOI: 10.4049/jimmunol.1201218

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  40 in total

1.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells.

Authors:  Jason D Fontenot; Marc A Gavin; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2003-03-03       Impact factor: 25.606

2.  Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene.

Authors:  B Sadlack; H Merz; H Schorle; A Schimpl; A C Feller; I Horak
Journal:  Cell       Date:  1993-10-22       Impact factor: 41.582

Review 3.  Tolerance, not immunity, crucially depends on IL-2.

Authors:  Thomas R Malek; Allison L Bayer
Journal:  Nat Rev Immunol       Date:  2004-09       Impact factor: 53.106

4.  Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis.

Authors:  M J Lenardo
Journal:  Nature       Date:  1991-10-31       Impact factor: 49.962

5.  Three distinct IL-2 signaling pathways mediated by bcl-2, c-myc, and lck cooperate in hematopoietic cell proliferation.

Authors:  T Miyazaki; Z J Liu; A Kawahara; Y Minami; K Yamada; Y Tsujimoto; E L Barsoumian; R M Permutter; T Taniguchi
Journal:  Cell       Date:  1995-04-21       Impact factor: 41.582

6.  Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta.

Authors:  H Suzuki; T M Kündig; C Furlonger; A Wakeham; E Timms; T Matsuyama; R Schmits; J J Simard; P S Ohashi; H Griesser
Journal:  Science       Date:  1995-06-09       Impact factor: 47.728

7.  CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rbeta-deficient mice. Implications for the nonredundant function of IL-2.

Authors:  Thomas R Malek; Aixin Yu; Vladimir Vincek; Paul Scibelli; Lin Kong
Journal:  Immunity       Date:  2002-08       Impact factor: 31.745

8.  Loss of epigenetic modification driven by the Foxp3 transcription factor leads to regulatory T cell insufficiency.

Authors:  Matthew L Bettini; Fan Pan; Maria Bettini; David Finkelstein; Jerold E Rehg; Stefan Floess; Bryan D Bell; Steven F Ziegler; Jochen Huehn; Drew M Pardoll; Dario A A Vignali
Journal:  Immunity       Date:  2012-05-10       Impact factor: 31.745

9.  Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting.

Authors:  H Schorle; T Holtschke; T Hünig; A Schimpl; I Horak
Journal:  Nature       Date:  1991-08-15       Impact factor: 49.962

10.  Interleukin 2 upregulates expression of its receptor on a T cell clone.

Authors:  T R Malek; J D Ashwell
Journal:  J Exp Med       Date:  1985-06-01       Impact factor: 14.307

View more
  47 in total

Review 1.  T Cells: Soldiers and Spies--The Surveillance and Control of Effector T Cells by Regulatory T Cells.

Authors:  Bruce M Hall
Journal:  Clin J Am Soc Nephrol       Date:  2015-04-15       Impact factor: 8.237

2.  The Lower Limit of Regulatory CD4+ Foxp3+ TCRβ Repertoire Diversity Required To Control Autoimmunity.

Authors:  Aixin Yu; Michael J Dee; Dennis Adeegbe; Connor J Dwyer; Norman H Altman; Thomas R Malek
Journal:  J Immunol       Date:  2017-03-06       Impact factor: 5.422

3.  Bone Marrow Mesenchymal Stromal Cells Induce Proliferative, Cytokinic and Molecular Changes During the T Cell Response: The Importance of the IL-10/CD210 Axis.

Authors:  Mehdi Najar; Gordana Raicevic; Hussein Fayyad-Kazan; Cécile De Bruyn; Dominique Bron; Michel Toungouz; Laurence Lagneaux
Journal:  Stem Cell Rev Rep       Date:  2015-06       Impact factor: 5.739

4.  IL-2 prevents deletion of developing T-regulatory cells in the thymus.

Authors:  Daniel Y Hu; Rushika C Wirasinha; Christopher C Goodnow; Stephen R Daley
Journal:  Cell Death Differ       Date:  2017-05-12       Impact factor: 15.828

Review 5.  Cytokine Signaling in the Development and Homeostasis of Regulatory T cells.

Authors:  Kevin H Toomer; Thomas R Malek
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-03-01       Impact factor: 10.005

6.  Altered homeostasis and development of regulatory T cell subsets represent an IL-2R-dependent risk for diabetes in NOD mice.

Authors:  Connor J Dwyer; Allison L Bayer; Carmen Fotino; Liping Yu; Cecilia Cabello-Kindelan; Natasha C Ward; Kevin H Toomer; Zhibin Chen; Thomas R Malek
Journal:  Sci Signal       Date:  2017-12-19       Impact factor: 8.192

Review 7.  The IL-2/IL-2R system: from basic science to therapeutic applications to enhance immune regulation.

Authors:  Allison L Bayer; Alberto Pugliese; Thomas R Malek
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

Review 8.  Beyond regulatory T cells: the potential role for IL-2 to deplete T-follicular helper cells and treat autoimmune diseases.

Authors:  André Ballesteros-Tato
Journal:  Immunotherapy       Date:  2014       Impact factor: 4.196

Review 9.  Induced regulatory T cells in inhibitory microenvironments created by cancer.

Authors:  Theresa L Whiteside
Journal:  Expert Opin Biol Ther       Date:  2014-06-17       Impact factor: 4.388

10.  IL-2/CD25: A Long-Acting Fusion Protein That Promotes Immune Tolerance by Selectively Targeting the IL-2 Receptor on Regulatory T Cells.

Authors:  Natasha C Ward; Aixin Yu; Alejandro Moro; Yuguang Ban; Xi Chen; Sunnie Hsiung; James Keegan; Jaren M Arbanas; Martine Loubeau; Anil Thankappan; Aaron P Yamniuk; Jonathan H Davis; Mary Struthers; Thomas R Malek
Journal:  J Immunol       Date:  2018-10-03       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.